MUC16 and urinary bladder carcinoma: Showcasing this aspect, a recent targeted investigation of the bladder cancer glycoproteome highlighted that specific MUC16 glycoforms (CA125 antigen) could be used to define subsets of chemoresistant patients, whereas no associations could be found based solely on the presence of the protein (30).